EyePoint (EYPT)
EyePoint on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as laboratory analytical instruments.
20.8M
Short interest
settlement 2026-09-30
5.4
Days to cover
-1.0 days vs prior
50.8%
Short share of volume
2026-10-09
47
Fails to deliver
settlement 2026-09-02
Wed 4 Nov
Next earnings
estimated date
$52K
Insider flow, 90 days
1 buys, 0 sells
As of 2026-10-09.
Short interest
FINRA, twice a month. The newest 24 settlements in the table, 48 in the chart. JSONAs of 30 September 2026, short interest in EYPT is 20,788,240 shares, up 2,677,479 shares over the last month. Over the last 48 readings it ranged from 6,715,395 shares (15 July 2025) to 20,788,240 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 3.9M shares a day that is 5.4 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/eypt" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-09-30 | 20,788,240 | +4.9% | 3,863,442 | 5.38 |
| 2026-09-15 | 19,809,561 | +9.4% | 3,079,759 | 6.43 |
| 2026-08-31 | 18,110,761 | -1.7% | 10,506,239 | 1.72 |
| 2026-08-14 | 18,426,891 | +2.3% | 2,024,578 | 9.10 |
| 2026-07-31 | 18,015,023 | +9.7% | 1,458,571 | 12.35 |
| 2026-07-15 | 16,425,378 | +8.7% | 1,590,009 | 10.33 |
| 2026-06-30 | 15,114,767 | +0.3% | 1,572,696 | 9.61 |
| 2026-06-15 | 15,077,303 | -0.1% | 1,089,633 | 13.84 |
| 2026-05-29 | 15,097,978 | +6.7% | 1,000,348 | 15.09 |
| 2026-05-15 | 14,152,914 | -0.2% | 838,595 | 16.88 |
| 2026-04-30 | 14,186,473 | +3.9% | 855,027 | 16.59 |
| 2026-04-15 | 13,659,042 | +2.0% | 857,198 | 15.93 |
| 2026-03-31 | 13,385,952 | +7.3% | 951,760 | 14.06 |
| 2026-03-13 | 12,478,689 | +14.8% | 1,660,054 | 7.52 |
| 2026-02-27 | 10,868,767 | +14.1% | 2,410,231 | 4.51 |
| 2026-02-13 | 9,529,005 | +10.3% | 1,212,516 | 7.86 |
| 2026-01-30 | 8,638,845 | +4.4% | 908,851 | 9.51 |
| 2026-01-15 | 8,272,026 | -4.2% | 969,032 | 8.54 |
| 2025-12-31 | 8,632,273 | +18.1% | 1,305,856 | 6.61 |
| 2025-12-15 | 7,308,090 | -7.3% | 1,101,735 | 6.63 |
| 2025-11-28 | 7,881,028 | -8.7% | 1,112,401 | 7.08 |
| 2025-11-14 | 8,632,226 | +14.2% | 1,468,435 | 5.88 |
| 2025-10-31 | 7,558,136 | -7.0% | 1,292,705 | 5.85 |
| 2025-10-15 | 8,125,396 | +1.5% | 1,498,424 | 5.42 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 9 October 2026, the short share of EYPT volume is 50.8%, down 18.8 points over the last five sessions. Over the last 30 readings it ranged from 26.2% (16 September 2026) to 69.7% (2 October 2026). The latest reading is in line with the 30-session average of 49.1%, on 617K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-09 | 314K | 617K | 50.8% | 100 |
| 2026-10-08 | 481K | 803K | 59.9% | 0 |
| 2026-10-07 | 590K | 1.0M | 58.6% | 0 |
| 2026-10-06 | 526K | 852K | 61.8% | 11 |
| 2026-10-05 | 589K | 981K | 60.1% | 9,230 |
| 2026-10-02 | 927K | 1.3M | 69.7% | 137 |
| 2026-10-01 | 506K | 1.1M | 44.5% | 500 |
| 2026-09-30 | 428K | 1.2M | 35.9% | 5,972 |
| 2026-09-29 | 343K | 1.1M | 31.1% | 13,040 |
| 2026-09-28 | 468K | 1.3M | 34.9% | 100 |
| 2026-09-25 | 407K | 728K | 55.9% | 0 |
| 2026-09-24 | 527K | 940K | 56.0% | 914 |
| 2026-09-23 | 464K | 775K | 59.9% | 1,978 |
| 2026-09-22 | 701K | 1.6M | 42.8% | 22,982 |
| 2026-09-21 | 460K | 1.7M | 26.5% | 0 |
| 2026-09-18 | 748K | 2.3M | 32.7% | 0 |
| 2026-09-17 | 1.6M | 3.8M | 42.5% | 6,338 |
| 2026-09-16 | 632K | 2.4M | 26.2% | 29,560 |
| 2026-09-15 | 657K | 1.8M | 37.5% | 45,220 |
| 2026-09-14 | 453K | 879K | 51.5% | 11 |
| 2026-09-11 | 729K | 1.1M | 69.3% | 1,907 |
| 2026-09-10 | 1.1M | 2.6M | 43.4% | 3,233 |
| 2026-09-09 | 782K | 1.3M | 60.8% | 8 |
| 2026-09-08 | 510K | 920K | 55.5% | 121 |
| 2026-09-04 | 486K | 790K | 61.5% | 3 |
| 2026-09-03 | 828K | 1.3M | 63.8% | 7,465 |
| 2026-09-02 | 1.1M | 2.2M | 51.7% | 831 |
| 2026-09-01 | 662K | 1.4M | 45.8% | 4,628 |
| 2026-08-31 | 540K | 1.3M | 41.3% | 15 |
| 2026-08-28 | 813K | 2.0M | 40.0% | 8,139 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 2 September 2026, the fails-to-deliver balance in EYPT is 47 shares, down 17,196 shares over the last settlement date. Over the last 30 readings it ranged from 9 shares (17 August 2026) to 169,131 shares (20 January 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-02 | 47 | $4.58 | $215 |
| 2026-08-27 | 17,243 | $4.99 | $86K |
| 2026-08-26 | 376 | $5.01 | $2K |
| 2026-08-25 | 365 | $4.87 | $2K |
| 2026-08-17 | 9 | $14.75 | $133 |
| 2026-07-29 | 30 | $11.96 | $359 |
| 2026-07-22 | 65 | $13.05 | $848 |
| 2026-07-08 | 79,890 | $14.02 | $1.1M |
| 2026-07-06 | 755 | $13.98 | $11K |
| 2026-06-25 | 489 | $14.40 | $7K |
| 2026-06-22 | 11,512 | $13.58 | $156K |
| 2026-06-15 | 58 | $13.03 | $756 |
| 2026-06-05 | 325 | $12.26 | $4K |
| 2026-05-21 | 1,903 | $12.50 | $24K |
| 2026-05-14 | 14 | $13.43 | $188 |
| 2026-05-13 | 18,403 | $13.62 | $251K |
| 2026-04-21 | 615 | $15.07 | $9K |
| 2026-04-17 | 150 | $14.81 | $2K |
| 2026-04-16 | 150 | $14.63 | $2K |
| 2026-04-15 | 150 | $14.34 | $2K |
| 2026-04-13 | 213 | $14.19 | $3K |
| 2026-03-17 | 6,682 | $13.45 | $90K |
| 2026-02-23 | 1,941 | $15.33 | $30K |
| 2026-02-19 | 242 | $14.36 | $3K |
| 2026-01-27 | 268 | $15.45 | $4K |
| 2026-01-22 | 4,046 | $15.53 | $63K |
| 2026-01-20 | 169,131 | $15.08 | $2.6M |
| 2026-01-06 | 29,449 | $17.43 | $513K |
| 2025-12-22 | 4,889 | $17.43 | $85K |
| 2025-12-16 | 79 | $16.40 | $1K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at EYPT reported 1 open-market buy worth $52K in the last 90 days and no open-market sells. Latest filing: Elston George (Chief Financial Officer) on 2026-08-20.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-20 | Elston George | Chief Financial Officer | Gift | 65K | $0.00 | $0 | 65K |
| 2026-08-20 | Elston George | Chief Financial Officer | J | 5K | $0.00 | $0 | 97K |
| 2026-08-20 | Elston George | Chief Financial Officer | Gift | 65K | $0.00 | $0 | 33K |
| 2026-08-20 | Elston George | Chief Financial Officer | J | 5K | $0.00 | $0 | 25K |
| 2026-08-18 | Zaderej Karen L. | Director | Buy | 11K | $4.93 | $52K | 49K |
| 2026-07-10 | Duker Jay S. | President and CEO | Tax withholding | 8K | $14.72 | $119K | 10K |
| 2026-07-10 | Duker Jay S. | President and CEO | Option exercise | 17K | $0.00 | $0 | 18K |
| 2026-06-30 | Ribeiro Ramiro | Chief Medical Officer | Sell | 2K | $15.02 | $37K | 0 |
| 2026-06-30 | Ribeiro Ramiro | Chief Medical Officer | Sell | 2K | $15.00 | $37K | 2K |
| 2026-06-30 | Ribeiro Ramiro | Chief Medical Officer | Option exercise | 2K | $8.26 | $20K | 5K |
| 2026-06-30 | Ribeiro Ramiro | Chief Medical Officer | Option exercise | 2K | $8.26 | $20K | 2K |
| 2026-05-25 | Elston George | Chief Financial Officer | Tax withholding | 4K | $12.93 | $47K | 92K |
| 2026-05-25 | Elston George | Chief Financial Officer | Option exercise | 8K | $0.00 | $0 | 95K |
| 2026-04-17 | Ribeiro Ramiro | Chief Medical Officer | Sell | 2K | $15.00 | $37K | 0 |
| 2026-04-17 | Ribeiro Ramiro | Chief Medical Officer | Option exercise | 2K | $8.26 | $20K | 2K |
| 2026-03-23 | Duker Jay S. | President and CEO | J | 77K | $13.11 | $1.0M | 177K |
| 2026-03-23 | Duker Jay S. | President and CEO | J | 77K | $13.11 | $1.0M | 986 |
| 2026-03-16 | Duker Jay S. | President and CEO | Buy | 2K | $13.15 | $20K | 101K |
| 2026-03-04 | Ribeiro Ramiro | Chief Medical Officer | Sell | 2K | $17.87 | $44K | 0 |
| 2026-03-04 | Ribeiro Ramiro | Chief Medical Officer | Option exercise | 2K | $8.26 | $20K | 2K |
| 2026-03-02 | Elston George | Chief Financial Officer | Gift | 5K | $0.00 | $0 | 30K |
| 2026-03-02 | Elston George | Chief Financial Officer | Gift | 5K | $0.00 | $0 | 88K |
| 2026-02-17 | Ribeiro Ramiro | Chief Medical Officer | Sell | 2K | $15.00 | $37K | 0 |
| 2026-02-17 | Ribeiro Ramiro | Chief Medical Officer | Option exercise | 2K | $8.26 | $20K | 2K |
| 2026-01-06 | Lurker Nancy | Director | Option exercise | 75K | $0.00 | $0 | 294K |
| 2026-01-06 | Elston George | Chief Financial Officer | Tax withholding | 4K | $16.86 | $76K | 92K |
| 2026-01-06 | Elston George | Chief Financial Officer | Option exercise | 15K | $0.00 | $0 | 96K |
| 2026-01-06 | Duker Jay S. | President and CEO | Tax withholding | 10K | $16.86 | $170K | 78K |
| 2026-01-06 | Duker Jay S. | President and CEO | Option exercise | 21K | $0.00 | $0 | 88K |
| 2026-01-05 | Lurker Nancy | Director | Option exercise | 13K | $0.00 | $0 | 219K |
| 2026-01-05 | Elston George | Chief Financial Officer | Tax withholding | 4K | $17.43 | $77K | 81K |
| 2026-01-05 | Elston George | Chief Financial Officer | Option exercise | 15K | $0.00 | $0 | 85K |
| 2026-01-05 | Duker Jay S. | President and CEO | Tax withholding | 15K | $17.43 | $253K | 67K |
| 2026-01-05 | Duker Jay S. | President and CEO | Option exercise | 30K | $0.00 | $0 | 82K |
| 2026-01-05 | Ribeiro Ramiro | Chief Medical Officer | Sell | 43K | $17.10 | $727K | 0 |
| 2026-01-05 | Ribeiro Ramiro | Chief Medical Officer | Option exercise | 29K | $8.26 | $242K | 43K |
| 2026-01-03 | Ribeiro Ramiro | Chief Medical Officer | Tax withholding | 6K | $17.48 | $111K | 13K |
| 2026-01-03 | Ribeiro Ramiro | Chief Medical Officer | Option exercise | 20K | $0.00 | $0 | 20K |
| 2026-01-03 | Elston George | Chief Financial Officer | Tax withholding | 6K | $17.48 | $111K | 70K |
| 2026-01-03 | Elston George | Chief Financial Officer | Option exercise | 20K | $0.00 | $0 | 77K |
| 2026-01-03 | Duker Jay S. | President and CEO | Tax withholding | 23K | $17.48 | $410K | 52K |
| 2026-01-03 | Duker Jay S. | President and CEO | Option exercise | 65K | $0.00 | $0 | 75K |
| 2025-12-19 | Elston George | Chief Financial Officer | Gift | 5K | $0.00 | $0 | 25K |
| 2025-12-19 | Elston George | Chief Financial Officer | Gift | 5K | $0.00 | $0 | 57K |
| 2025-12-04 | Lurker Nancy | Director | Sell | 9K | $15.11 | $140K | 207K |
| 2025-12-04 | Cormorant Asset Management, LP | Former 10% Owner | Sell | 60K | $15.70 | $942K | 8.3M |
| 2025-11-28 | Lurker Nancy | Director | Sell | 500 | $14.95 | $7K | 216K |
| 2025-11-26 | Lurker Nancy | Director | Sell | 200 | $14.95 | $3K | 216K |
| 2025-11-11 | Ribeiro Ramiro | Chief Medical Officer | Sell | 3K | $11.61 | $32K | 0 |
| 2025-09-19 | Elston George | Chief Financial Officer | Gift | 20K | $0.00 | $0 | 20K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON9 Form 144 notices on file for EYPT worth $6.8M at the prices reported; 3 in the last 90 days worth $5.5M. Latest: Lurker Nancy filed on 2026-07-22 to sell 1,235 shares ($16K) from 2026-07-22.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-07-22 | Lurker NancyDirector | 1K | $16K | 0.001% | 2026-07-22 | Fidelity Brokerage Services |
| 2026-07-22 | Lurker NancyOfficer | 1K | $16K | 0.001% | 2026-07-22 | Fidelity Brokerage Services |
| 2026-07-21 | Lurker NancyOfficer | 421K | $5.5M | 0.502% | 2026-07-21 | Fidelity Brokerage Services |
| 2026-04-17 | Ramiro RibeiroOfficer | 10K | $144K | 0.012% | 2026-04-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-01-05 | Ramiro RibeiroOfficer | 54K | $940K | 0.065% | 2026-01-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-04 | Lurker NancyOfficer | 9K | $140K | 0.011% | 2025-12-04 | Fidelity Brokerage Services |
| 2025-11-28 | Lurker NancyOfficer | 500 | $7K | 0.001% | 2025-11-28 | Fidelity Brokerage Services |
| 2025-11-26 | Lurker NancyOfficer | 200 | $3K | 0.000% | 2025-11-26 | Fidelity Brokerage Services |
| 2025-11-12 | Ramiro RibeiroOfficer | 3K | $31K | 0.003% | 2025-11-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON18 holders report 5% or more of EYPT in their latest filing, all on Schedule 13G (passive). The largest reported stake is JANUS HENDERSON GROUP Ltd. at 10.9% of the class (9,366,332 shares), filed 2026-09-08 for an event on 2026-08-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-07 | 13G/Ano. 2 | J. Christopher Donahueindividual | 6.9M | 8.0% | 2026-09-30 |
| 2026-10-07 | 13G/Ano. 2 | Ann C. Donahueindividual | 6.9M | 8.0% | 2026-09-30 |
| 2026-10-07 | 13G/Ano. 2 | Thomas R. Donahueindividual | 6.9M | 8.0% | 2026-09-30 |
| 2026-10-07 | 13G/Ano. 2 | Voting Shares Irrevocable Trustother entity | 6.9M | 8.0% | 2026-09-30 |
| 2026-10-07 | 13G/Ano. 2 | Federated Hermes, Inc.parent holding company | 6.9M | 8.0% | 2026-09-30 |
| 2026-09-08 | 13G | JANUS HENDERSON GROUP Ltd.parent holding company | 9.4M | 10.9% | 2026-08-31 |
| 2026-08-14 | 13G/Ano. 4 | Cormorant Asset Management, LPinvestment adviser, partnership | 7.0M | 8.3% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 4 | Bihua Chenparent holding company, individual | 7.0M | 8.3% | 2026-06-30 |
| 2026-08-12 | 13G | Adage Capital Management, L.P.investment adviser, partnership | 4.8M | 5.7% | 2026-06-30 |
| 2026-08-12 | 13G | Robert Atchinsonparent holding company, individual | 4.8M | 5.7% | 2026-06-30 |
| 2026-08-12 | 13G | Phillip Grossparent holding company, individual | 4.8M | 5.7% | 2026-06-30 |
| 2026-07-31 | 13G | Vanguard Capital Managementinvestment adviser | 4.2M | 5.0% | 2026-06-30 |
| 2026-07-28 | 13G/Ano. 2 | BlackRock, Inc.parent holding company | 6.4M | 7.7% | 2026-06-30 |
| 2026-06-03 | 13G | Commodore Capital LPinvestment adviser, partnership | 4.3M | 5.1% | 2026-05-27 |
| 2026-06-03 | 13G | Commodore Capital Master LPpartnership | 4.3M | 5.1% | 2026-05-27 |
| 2026-06-03 | 13G | Robert Egen Atkinsonparent holding company, individual | 4.3M | 5.1% | 2026-05-27 |
| 2026-06-03 | 13G | Michael Kramarzparent holding company, individual | 4.3M | 5.1% | 2026-05-27 |
| 2026-05-15 | 13G/Ano. 1 | Paradigm BioCapital Advisors LPpartnership | 3.1M | 3.8% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Paradigm BioCapital Advisors GP LLCother entity | 3.1M | 3.8% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Senai Asefaw, M.D.individual | 3.1M | 3.8% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Paradigm BioCapital International Fund Ltd.corporation | 2.8M | 3.3% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 2 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-17 | 13G/Ano. 1 | TCG Crossover GP II, LLCother entity | 3.6M | 4.3% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | TCG Crossover Fund II, L.P.partnership | 3.6M | 4.3% | 2025-12-31 |
| 2026-02-17 | 13G/Ano. 1 | Chen Yuindividual | 3.6M | 4.3% | 2025-12-31 |
| 2025-12-08 | 13G/Ano. 3 | Chen Bihuaindividual, parent holding company | 8.3M | 10.0% | 2025-12-04 |
13F holders
Tracked managers holding EYPT at their latest 13F. JSON4 of the 30 tracked managers held EYPT at their latest 13F, $53.0M in total at quarter-end prices. Citadel Advisors is the largest at $28.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 2.0M | $28.3M | 0.00% | +72K |
| Two Sigma Investments | 2026-06-30 | 1.2M | $16.9M | 0.01% | +751K |
| Millennium Management | 2026-06-30 | 500K | $7.2M | 0.00% | +25K |
| Point72 Asset Management | 2026-06-30 | 49K | $695K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) EyePoint reported revenue of $507K, down 90.5% from the same quarter a year earlier, and net loss of $94.5M (-1.09 diluted EPS). In FY 2025 it generated -$240.1M of operating cash flow.
- Cash
- $110.5M
- Equity
- $166.4M
- Total assets
- $228.2M
- Shares outstanding
- 86,212,138
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $507K | -$94.5M | -18633.1% | -1.09 |
| Q1 FY 2026 | 2026-03-31 | $696K | -$84.8M | -12188.5% | -0.99 |
| Q4 FY 2025derived | 2025-12-31 | $619K | n/a | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | $966K | -$59.7M | -6183.4% | -0.85 |
| Q2 FY 2025 | 2025-06-30 | $5.3M | -$59.4M | -1114.3% | -0.85 |
| Q1 FY 2025 | 2025-03-31 | $24.5M | -$45.2M | -184.8% | -0.65 |
| Q4 FY 2024derived | 2024-12-31 | $11.6M | n/a | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | $10.5M | -$29.4M | -279.0% | -0.54 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $31.4M | -$232.0M | -$240.1M | $3.3M | n/a | n/a |
| FY 2024 | 2024-12-31 | $43.3M | -$130.9M | -$126.2M | $4.1M | n/a | n/a |
| FY 2023 | 2023-12-31 | $46.0M | -$70.8M | $1.9M | $3.5M | n/a | n/a |
| FY 2022 | 2022-12-31 | $41.4M | -$102.3M | -$65.0M | $2.1M | n/a | n/a |
| FY 2021 | 2021-12-31 | $36.9M | -$58.4M | -$50.1M | $156K | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
EyePoint in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows EyePoint (EYPT), SEC CIK 1314102, listed on Nasdaq, classified by the SEC as laboratory analytical instruments. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-09-30.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-09.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-02.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-07-22.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-07.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-05.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-20.JSON and CSV
- Company record
- EDGAR filing index for CIK 1314102Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as laboratory analytical instruments
Other company pages
Datasets
Frequently Asked Questions
How much of EYPT is sold short?
What is EYPT's daily short volume?
Does EYPT have fails to deliver?
Are EYPT insiders buying or selling?
Have EYPT insiders filed to sell?
Who owns 5% or more of EYPT?
What did EYPT report last quarter?
Which tracked 13F managers own EYPT?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.